SGO Conference Schedule
Friday, March 18th: 7:00 AM – 12:30 PM Debulk and Deliver: Hands-On Cytoreductive Surgery Lab 8:00 AM – 12:00 PM Master Class: Rare but Revelatory: Clinical Updates & Research Advancements in Uncommon Gynecologic...
Read MorePre Conference (Meeting Coverage)
Health and Safety at ASCO GU 2022
Individual Accountability ASCO is committed to maintaining the health and safety of all ASCO Genitourinary Cancers Symposium attendees. We will be reviewing the latest Centers for Disease Control and Prevention and World Health...
Read MoreActive Surveillance Helps Delay Systemic Therapy in Some With Metastatic Renal Cell Carcinoma
Active surveillance (AS) may be used effectively in a subgroup of patients(pts) with metastatic renal cell carcinoma (RCC) and indolent disease to postpone the commencement of systemic treatment without affecting long-term...
Read MoreMindfulness App Helps Address Psychosocial Distress in Patients With Metastatic Renal Cell Carcinoma
mRCC was linked to a high incidence of distress, a high degree of symptom load, and a wide range of quality-of-life impairments. A smartphone application aimed at enhancing mindfulness has been developed from a Mindfulness-Based...
Read MoreTele-mentoring Benefits Patients With Renal Cell Carcinoma
In recent years, the overall survival from metastatic renal cell carcinoma (RCC) has improved, mainly in part due to immune checkpoint inhibitors (ICI) and tyrosine kinase inhibitors (TKI). TKI and ICI had distinct and...
Read MoreResponse to Lenvatinib + Pembrolizumab in Advanced Renal Cell Carcinoma Regardless of Biomarker Status
Lenvatinib (lenva) + pembrolizumab (pembro) demonstrated encouraging antitumor activity and controllable safety characteristics in treatment-naive (n=23) or earlier cured metastatic RCC (n=105, initially medicated with immune...
Read MoreASCO GU Program Guide 2022
Thursday, Feb 17: Exhibits Open 10:00 AM – 9:45 PM EST Novel Treatment Implementation: Prostate-Specific Membrane Antigen Targeting and Beyond Primary Track: Prostate Cancer 10:45 AM – 12:30 PM EST Optimizing Management of...
Read MoreASCO GU 2022 Is Here!
Program at a Glance • Highly interactive sessions with multidisciplinary perspectives on new, innovative findings in the study, diagnosis, and treatment of GU malignancies. • Presentation of the latest novel science and...
Read More
Presentation Format at a Glance at ESC 2021
Download ESC Congress 2021 Program (PDF)
Read MoreIt’s Time! ESC Congress 2021 is Here
Anticipation is rising for the European Society’s Annual Congress, an event like no other, providing access to ground-breaking science, essential clinical updates and the chance to interact with a renowned international...
Read More2021 AAN Annual Meeting Kick-Off!
Due to the COVID-19 pandemic, the 2021 American Academy of Neurology Annual Meeting, the world’s premier neurology meeting, will be held in a fully virtual format from April 17-22. It will include: Over 90 expert-led CME...
Read MoreAAN 2021: Disability Accrual in Primary Progressive & Secondary Progressive Multiple Sclerosis
The study team compared disability accrual in primary and secondary progressive multiple sclerosis (PPMS, SPMS) in the international MSBase cohort, using multivariable survival models, and applying objective diagnostic criteria...
Read MoreAAN 2021: Influencing And Optimizing The Management Of Patients With MS
Management of patients with multiple sclerosis (MS) in the era of disease modifying therapies (DMT) relies heavily on magnetic resonance imaging (MRI). As physicians, decisions are influenced by the reporting prowess of...
Read More